Barr Plan B OTC Should Not Be Kept Behind Pharmacy Counter, Cmte. Says
Executive Summary
Barr's Plan B emergency contraceptive should be available without a prescription and not restricted to "behind-the-counter" distribution at pharmacies, FDA's Reproductive Health and Nonprescription Drugs Advisory Committees said Dec. 16
You may also be interested in...
Galson Backed Initial Plan B Denial In Fear His Job Was In Jeopardy – Jenkins
Center for Drug Evaluation & Research Director Steven Galson initially signed off on the "not approvable" letter for Barr's emergency contraceptive Plan B OTC switch in fear that he would lose his job, according to testimony by senior CDER officials
Galson Backed Initial Plan B Denial In Fear His Job Was In Jeopardy – Jenkins
Center for Drug Evaluation & Research Director Steven Galson initially signed off on the "not approvable" letter for Barr's emergency contraceptive Plan B OTC switch in fear that he would lose his job, according to testimony by senior CDER officials
Plan B Approval Clears The Way For Von Eschenbach Confirmation
FDA's decision to approve the emergency contraceptive Plan B for over-the-counter sale to women age 18 and older opens the door to a vote on FDA Acting Commissioner Andrew von Eschenbach's nomination to the permanent post